Aetna agrees to cover iRhythm's cardiac monitoring patch

San Francisco's iRhythm Technologies won coverage from a major insurer for its flagship arrhythmia monitoring patch, a big win in what has become a brutal reimbursement environment for many med tech companies. Aetna, the third biggest private health insurer in the U.S., will cover iRhythm's ZIO Service that provides long-term continuous monitoring for patients with suspected heart arrhythmias. The company insists that its technology can help boost patient outcomes and reduce healthcare costs--the kind of pitch that gains attention in the current healthcare climate. The system includes a water-resistant patch that captures and analyzes heart data. It represents a major advance over the current standard of care: monitors worn over the neck, like a necklace, that are connected to the chest via wires and conductive patches. ZIO launched commercially in 2011. Item

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.